This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The company has partnerships with organizations such as the Mayo Clinic, the University of California, San Francisco, and the Veterans Health Administration. Palantir's products are also being used by pharmaceutical companies, medical device manufacturers, and healthcare payers. Palantir's plans for healthcare are ambitious.
The Phase IV trial, funded by a top-10 global pharmaceutical company, had a narrow recruitment window to enroll patients suffering from Anemia in End Stage Kidney Disease (ESKD) across more than 40 dialysis centers, involving 476 site users. .–(BUSINESS WIRE)– Medable Inc. , Renal Care ’s (USRC) investigator-initiated trial.
The company has partnerships with organizations such as the Mayo Clinic, the University of California, San Francisco, and the Veterans Health Administration. Palantir's products are also being used by pharmaceutical companies, medical device manufacturers, and healthcare payers. Palantir's plans for healthcare are ambitious.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Drug Development 
91 
Let's personalize your content